Evaluation of mesoporous silicate nanoparticles for the sustained release of the anticancer drugs: 5-fluorouracil and 7-hydroxycoumarin
Source abstract
Abstract
In this study, effects of chemical structure and molecular size of the anticancer drugs 5-fluorouracil and 7-hydroxycoumarin on their release from MCM-48 nanoparticles were investigated. Nanoparticles of the mesoporous silicate material, MCM-48, were prepared and characterized by XRD, SEM and FTIR. Loading of 5-fluorouracil and 7-hydroxycoumarin onto the nanoparticles was confirmed by FTIR and TGA measurements, and loading capacities of about 24 and 14 % were achieved, respectively. Release experiments for 5-fluorouracil were conducted in buffer solutions at pH = 7.4 and 5.2. However, due to the instability of 7-hydroxycoumarin in basic media, release experiments were conducted only in acidic buffer solution at pH = 5.2. The release of 5-fluorouracil was slightly affected by the pH of the release medium, and it was almost complete in about 2 h. However, the release of 7-hydroxycoumarin which has a larger size and higher acidity followed a prolonged release mode over a period of 12 h. The prolonged release of 7-hydroxycoumarin from MCM-48 nanoparticles points out to the potential use of this system as sustained release delivery carrier.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Chemical Synthesis and Characterization · Clay minerals and soil interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (33)
Show source-provided references
1. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J (2001) A new property of MCM-41: drug delivery system. Chem Mater 13:30810.1021/cm0011559 ↗
2. Ma P, Xiao H, Li C, Dai Y, Cheng Z, Hou Z, Lin J (2015) Inorganic nanocarriers for platinum drug delivery. Mater Today 18:55410.1016/j.mattod.2015.05.017 ↗
3. Vallet-Regi M (2012) Mesoporous silica nanoparticles: their projection in nanomedicine. Int Scholarly Res Netw Mater Sci, Article ID 608548: 110.5402/2012/608548 ↗
4. Santos HA, Salonen J, Bimbo LM, Lehto V-P, Peltonen L, Hirvonen J (2011) Mesoporous materials as controlled drug delivery formulation. J Drug Del Sci Tech 21:13910.1016/S1773-2247(11)50016-4 ↗
5. Slowing II, Vivero-Escoto JL, Wu C, Lin VS-Y (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliver Rev 60:127810.1016/j.addr.2008.03.012 ↗
6. Vallet-Regi M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46:754810.1002/anie.200604488 ↗
7. Frenzer G, Maier WF (2006) Amorphous porous mixed oxide: Sol–Gel ways to a highly versatile class of materials and catalysts. Annu Rev Mater Res 36:28110.1146/annurev.matsci.36.032905.092408 ↗
8. Walcarius A, Mercier L (2010) Mesoporous organosilica adsorbents: nanoengineered materials for removal of organic and inorganic pollutants. J Mater Chem 20:447810.1039/b924316j ↗
9. Izquierdo-Barba I, Martinez A, Doadrio AL, P´erez-Pariente J, Vallet-Reg M (2005) Release evaluation of drugs from ordered three-dimensional silica structures. Eur J Pharm Sci 26:36510.1016/j.ejps.2005.06.009 ↗
10. Izquierdo-Barba I, Sousa E, Doadrio JC, Doadrio AL, Pariente JP, Martı´nez A, Babonneau F, Vallet-Regi M (2009) Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. J Sol-Gel Sci Technol 50:42110.1007/s10971-009-1932-3 ↗
11. Suri SS, Fenniri H, Singh B (2007) Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2:1610.1186/1745-6673-2-16 ↗
12. Popat A, Liu J, Hu Q, Kennedy M, Peters B, Lu GQ, Qia SZ (2012) Adsorption and release of biocides with mesoporous silica nanoparticles. Nanoscale 4:97010.1039/C2NR11691J ↗
13. Vafaee M, Amini MM, Najafi E, Sadeghi O, Amani V (2012) Modified nanoporous silicas for oral delivery of the water insoluble organo tin compound: loading and release of methylphenyltin dichloride as an anti-tumor drug model. J Sol-Gel Sci Technol 64:41110.1007/s10971-012-2871-y ↗
14. Aghaei H, Nourbakhsh AA, Karbasi S, Kalbasi RJ, Rafienia M, Nourbakhsh N, Bonakdar S, Mackenzie KJD (2014) Investigation on bioactivity and cytotoxicity of mesoporous nanocomposite MCM-48/hydroxyapatite for Ibuprofen drug delivery. Ceram Int 40:735510.1016/j.ceramint.2013.12.079 ↗
15. Jung J, Lee IH, Lee E, Park J, Jon S (2007) pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle. Biomacromolecules 8:340110.1021/bm700517z ↗
16. Li S, Wang A, Jiang W, Guan Z (2008) Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BioMed Central Cancer 8:103
17. Parrella A, Lavorgna M, Criscuolo E, Russo C, Isidori M (2014) Estrogenic activity and cytotoxicity of six anticancer drugs detected in water systems. Sci Total Environ 485–486:21610.1016/j.scitotenv.2014.03.050 ↗
18. Diasio RB, Harris BE (1989) Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16:21510.2165/00003088-198916040-00002 ↗
19. Di Paolo A, Danesi R, Falcone A, Cionini L, Vannozzi F, Masi G, Allegrini G, Mini E, Bocci G, Contes PF, Del Tacca M (2001) Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients. Ann Oncol 12:130110.1023/A:1012294617392 ↗
20. Lin P, Yeh K, Su C, Sheu S, Chen T, Ou K, Lin M, Lee L (2012) Synthesis and antibacterial activities of novel 4-Hydroxy-7-hydroxy- and 3-Carboxycoumarin derivatives. Molecules 17:1084610.3390/molecules170910846 ↗
21. Weber US, Steffen B, Siegers CP (1998) Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Res Commun Mol Path pharmacol 99:193
22. Ritschel WA, Grummich KW, Kaul S, Hardt TJ (1981) Biopharmaceutical parameters of coumarin and 7-hydroxycoumarin. Pharm Ind 43:271
23. Ritschel WA, Brady ME, Tan HS, Hoffmann KA, Yiu IM, Grummich KW (1977) Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 12:45710.1007/BF00561066 ↗
24. Tian L, Yang J, Ji F, Liu Y, Yao F (2014) Drug co-loading and pH-sensitive release core-shell nanoparticlesvia layer-by-layer assembly. J Biomater Sci Polym Ed 25:157310.1080/09205063.2014.926000 ↗
25. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T (2003) Preparation and assessment of revised simulated body fluids. J. Biomed. Mater Res A 65:18810.1002/jbm.a.10482 ↗
26. Kim T, Chung P, Lin VS-Y (2010) Facile synthesis of monodisperse spherical MCM-48 mesoporous silica nanoparticles with controlled size. Chem Mater 22:509310.1021/cm1017344 ↗
27. Pantazis CC, Trikalitis PN, Pomonis PJ, Hudson MJ (2003) A method of synthesis of silicious inorganic ordered materials (MCM-41–SBA-1) employing polyacrylic acid–CnTAB–TEOS nanoassemblies. Micropor Mesopor Mater 66:3710.1016/j.micromeso.2003.08.017 ↗
28. Datt A, Burns EA, Dhuna NA, Larsen SC (2013) Loading and release of 5-fluorouracil from HY zeolites with varying SiO2/Al2O3 ratios. Microporous Mesoporous Mater 167:18210.1016/j.micromeso.2012.09.011 ↗
29. Heikkila T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, Hamdy MS, Mul G, Laitinen L, Kaukonen AM, Hirvonen J, Lehto V-P (2007) Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv 14:33710.1080/10717540601098823 ↗
30. Costa P, Lobo JMS (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:12310.1016/S0928-0987(01)00095-1 ↗
31. Huguchi T (1963) Mechanism of sustained-action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:114510.1002/jps.2600521210 ↗
32. Kopcha M, Lordi NG, Tojo KJ (1991) Evaluation of release from selected thermosoftening vehicles. J Pharm Pharmacol 43:38210.1111/j.2042-7158.1991.tb03493.x ↗
33. Garrett ER, Lippold BC, Mielck JB (1971) Kinetics and mechanisms of lactonization of coumarinic acids and hydrolysis of coumarins I. J Pharm Sci 60:39610.1002/jps.2600600312 ↗